SLAI Q4 2024 Earnings EPS Misses Estimates as Company Reports Loss per Share GROY Q1 2026 Earnings Slight EPS Miss Amidst Quiet Quarter Murphy USA Inc MUSA Q1 2026 Earnings Earnings Surge Past Estimates Stock Slips Marginally BCML Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency ESCA Q1 2026 Earnings EPS Surges 74 Above Estimates Stock Moves Higher PBYI Q1 2026 Earnings NarrowerThanExpected Loss Signals Operational Discipline XYF Q1 2020 Earnings Massive EPS Miss Amidst Pandemic Uncertainty SCHW Q1 2026 Earnings Modest EPS Beat Amid Steady Performance DBI Q1 2026 Earnings EPS Surprise Amid Persistent Retail Challenges CNP Q1 2026 Earnings EPS Misses Estimate by a Narrow Margin Stock Edges Higher Oscar Health Inc OSCR Q1 2026 Earnings Massive EPS Beat Signals Strong Underwriting ESPR Q1 2026 Earnings EPS Misses Estimates as Revenue Goes Unreported Mobile Infrastructure Corporation BEEP Q1 2026 Earnings Narrow EPS Beat Fails to Stem Stock Decline CASS Q1 2026 Earnings EPS Beats Estimates by Nearly 6 Stock Edges Lower INTR Q1 2026 Earnings EPS Miss Weighs on Shares Despite Solid Operational Progress Community Healthcare Trust CHCT Q1 2026 Earnings Massive EPS Beat Masks Continued Market Caution Halozyme Therapeutics Inc HALO Q1 2026 Earnings EPS Surpasses Estimates Despite Flat Revenue Disclosure CRISPR Therapeutics Q1 2026 Earnings Slight EPS Miss as Clinical Pipeline Progresses C4 Therapeutics Q1 2026 Earnings EPS Surprises to the Upside as Biotech Focuses on Pipeline Execution